NEW YORK, Oct. 15-California's NuGen Technologies will work with researchers at the Genome Institute of Singapore to develop microarray-based amplification and gene expression analysis technologies, the company said today.
The partners will develop NuGen's Single Primer Isothermal Amplification platform, which is a linear amplification technique. Researchers will adapt its gene expression application, Ribo-SPIA, to work with the Singaporean institute's custom-made oligonucleotide microarrays.
Financial details of the partnership were not revealed.
NuGen is a privately held company based in San Carlos, Calif. The company is working to develop a gene expression analysis product that can function with sample sizes of less than 20 ng of RNA.